Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -12.93 is 72% above its 5-year average of -45.71, near the high end of its 5-year range (-103.61–-10.21).
9.16% below its 12-month average of -11.85.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -2.87.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 26 comparable quarters.
EARNINGS PER SHARE (EPS)
-12.93
EARNINGS PER SHARE (EPS) AVG TTM
-11.85
EARNINGS PER SHARE (EPS) AVG 3Y
-27.93
EARNINGS PER SHARE (EPS) AVG 5Y
-45.71
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-9.16%
CURRENT VS 3Y AVG
+53.70%
CURRENT VS 5Y AVG
+71.72%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Praxis Precision Medicines, Inc.
Market Cap
$7.72B
Earnings Per Share (EPS)
-12.93
TTM Avg
-11.85
3Y Avg
-27.93
5Y Avg
-45.71
Market Cap
$7.77B
Earnings Per Share (EPS)
0.36
TTM Avg
-1.91
3Y Avg
-1.77
5Y Avg
-0.94
Market Cap
$7.62B
Earnings Per Share (EPS)
-7.22
TTM Avg
-5.90
3Y Avg
-5.40
5Y Avg
-4.39
Market Cap
$7.61B
Earnings Per Share (EPS)
2.77
TTM Avg
1.81
3Y Avg
0.99
5Y Avg
0.59
Market Cap
$7.58B
Earnings Per Share (EPS)
1.29
TTM Avg
-2.76
3Y Avg
-2.30
5Y Avg
-2.30
Market Cap
$8.04B
Earnings Per Share (EPS)
2.74
TTM Avg
1.63
3Y Avg
0.47
5Y Avg
-0.53
Market Cap
$7.32B
Earnings Per Share (EPS)
-3.46
TTM Avg
-2.71
3Y Avg
-2.47
5Y Avg
-2.21
Market Cap
$8.40B
Earnings Per Share (EPS)
1.40
TTM Avg
-0.79
3Y Avg
-1.41
5Y Avg
-1.76
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Praxis Precision Medicines, Inc. (PRAX) | $7.72B | -12.93 | -11.85 | -27.93 | -45.71 |
| Caris Life Sciences, Inc. (CAI)vs › | $7.77B | 0.36 | -1.91 | -1.77 | -0.94 |
| Cytokinetics, Incorporated (CYTK)vs › | $7.62B | -7.22 | -5.90 | -5.40 | -4.39 |
| HealthEquity, Inc. (HQY)vs › | $7.61B | 2.77 | 1.81 | 0.99 | 0.59 |
| Hinge Health, Inc. (HNGE)vs › | $7.58B | 1.29 | -2.76 | -2.30 | -2.30 |
| TG Therapeutics, Inc. (TGTX)vs › | $8.04B | 2.74 | 1.63 | 0.47 | -0.53 |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.32B | -3.46 | -2.71 | -2.47 | -2.21 |
| Oscar Health, Inc. (OSCR)vs › | $8.40B | 1.40 | -0.79 | -1.41 | -1.76 |
| Alkermes plc (ALKS)vs › | $7.00B | 0.38 | 1.85 | 1.22 | 0.64 |
| Kymera Therapeutics, Inc. (KYMR)vs › | $8.68B | -3.25 | -3.33 | -3.02 | -2.52 |
Trailing EPS (TTM)
$-12.93
Forward EPS (Est.)
$-13.60
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -13.48 |
| 2024-12-31 | -10.21 |
| 2023-12-31 | -18.69 |
| 2022-12-31 | -69.33 |
| 2021-12-31 | -58.96 |
| 2020-12-31 | -103.61 |
| 2019-12-31 | -348.24 |
| 2018-12-31 | -306.73 |
